PROC
Procaps Group SAKey Statistics
About Procaps Group SA
Procaps Group SA (PROC) is a prominent pharmaceutical and healthcare company in Latin America, recognized for its high-quality pharmaceutical products and nutraceuticals. Committed to innovation, Procaps employs cutting-edge technologies to develop value-added solutions, thereby solidifying its role as a significant contributor to the expanding healthcare sector. The company boasts a strong manufacturing infrastructure and cultivates strategic partnerships to enhance its distribution across key regional markets. Additionally, Procaps emphasizes sustainability and social responsibility, aligning its operations with global health trends and the rising consumer demand for health and wellness products.
Fundamentals
| Revenue (TTM) | $414.10M |
| Gross Profit (TTM) | $227.91M |
| EBITDA | $57.06M |
| Operating Margin | 11.10% |
| Return on Equity | 37.40% |
| Return on Assets | 6.28% |
| Revenue/Share (TTM) | $4.10 |
| Book Value | $0.39 |
| Price-to-Book | 64.34 |
| Price-to-Sales (TTM) | 0.28 |
| EV/Revenue | 6.76 |
| EV/EBITDA | 22.67 |
| Quarterly Earnings Growth (YoY) | -63.70% |
| Quarterly Revenue Growth (YoY) | 7.30% |
| Shares Outstanding | $112.82M |
| Float | $17.15M |
| % Insiders | 83.03% |
| % Institutions | 2.92% |
Historical Volatility
Volatility is currently contracting
Turn research into an automated options-selling system
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on PROC and any ticker you trade — then tracks every position and per-strategy win rate.